Contact
GENERAL INQUIRIES
Have questions for FDA Reporter? Have a tip or a lead? Please contact us!
Email: news@fdareporter.com
Trending
- 1 FUNCTIONAL NEUROMODULATION: Announces Breakthrough Device Designation from the U.S. FDA for Deep Brain Stimulation for Alzheimer's Disease
- 2 LOCATE BIO: CognitOss Granted FDA Breakthrough Device Designation
- 3 PROVENTION BIO: Announces U.S. FDA Filing of a Biologics License Application (BLA) and Priority Review for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-risk Individuals
- 4 ASTELLAS PHARMA INC.: FDA Accepts for Priority Review the New Drug Application for mirabegron for Oral Suspension and Supplemental New Drug Application for Myrbetriq® (mirabegron) Tablets in Pediatric Patients
Newsletter
Get the latest business news and updates - delivered right to your inbox
By signing up you agree to receive email newsletters or alerts from FDA Reporter. You can unsubscribe at any time.